Suit Targets Impax's Move To Sell Generic Amrix
Impax Laboratories Inc. said Thursday it has been tied into a patent infringement suit over its plans to market a generic Amrix, a skeletal muscle relaxant produced by Pennsylvania-based Cephalon Inc....To view the full article, register now.
Already a subscriber? Click here to view full article